A patient with alcoholic liver failure referred for liver transplantation

Liver Transplantation

Volumn 13, Issue 11 SUPPL. 2, 2007, Pages

  Mathurin, Philippe ^a   Lucey, Michael R ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; ALCOHOLISM; ANAMNESIS; ARTICLE; ASCITES; CASE REPORT; CLINICAL EXAMINATION; DRINKING BEHAVIOR; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT REFERRAL; PRIORITY JOURNAL; SYMPTOM;

EID: 36448947637     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21338     Document Type: Article

References (34)

1. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119:1637-1648.
2. Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann Intern Med 1989; 110:685-690.
3. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, et al. Survival and prognostic factors in patients with severe biopsy-proven alcoholic hepatitis treated by prednisolone: randomized trial, new cohort, and simulation. Gastroenterology 1996;110:1847-1853.
4. Mathurin P, Mendenhall C, Carithers RL Jr, Ramond MJ, Maddrey WC, Garstide P, et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials. J Hepatol 2002;36:480-487.
5. Ramond MJ, Poynard T, Rueff B, Mathurin P, Theodore C, Chaput JC, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-512.
6. Mathurin P, Abdelnour M, Ramond MJ, Carbonnell N, Fartoux L, Serfaty L, et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone. Hepatology 2003;38:1363-1369.
7. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45:1348-1354.
8. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003;37:233-243.
9. Poynard T, Barthelemy P, Fratte S, Boudjema K, Doffoel M, Vanlemmens C, et al. Evaluation of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 1994;344:502-507.
10. Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. J Hepatol 1999;30: 1130-1137.
11. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
12. Merion RM, Schaubel DE, Dykstra DL, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313.
13. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al, for Committee, United Network for Organ Sharing Liver Disease Severity Score. Model for End-Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
14. Olthoff KM, Brown Jr RS, Delmonico FL, Freeman RB, MrDiarmid SV, Merion RM, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10:A6-A22.
15. Berlakovich GA, Steininger R, Herbst F, Barlan M, Mittlbock M, Muhlbacher F. Transplantation for alcoholic cirrhosis: how does recurrence of disease harm the graft? Transpl. Int 1994:7:S123-S127.
16. Yates WR, Martin M, LaBrecque D, Hillebrand D, Voigt M, Pfab D. A model to examine the validity of the 6-month abstinence criterion for liver transplantation. Alcohol Clin Exp Res 1998;22:513-517.
17. Miguet M, Monnet E, Vanlemmens C, Gache P, Messner M, Hruskovsky S, et al. Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. Gastroenterol Clin Biol 2004;28:845-851.
18. Bird JLA, O'Grady JG, Harvey FAH, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990;301:15-17.
19. Bravata DM, Olkin I, Barnato AE, Keeffe EB, Owens DK. Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: a systematic review. Liver Transpl 2001;7:191-203.
20. Foster PF, Fabrega F, Karademir S, Sankary HN, Mital D, Williams JW. Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology 1997;25:1469-1477.
21. Kumar S, Stauber RE, Gavaler JS, Basista MH, Dindzans VJ, Schade RR, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990;11:159-164.
22. Osorio RW, Ascher NL, Avery M, Bachetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20: 105-110.
23. Beresford TP, Everson GT. Liver transplantation for alcoholic liver disease: bias, beliefs, 6-month rule, and relapse - but where are the data. Liver Transpl 2000;6:777-778.
24. Consensus conference. Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congres. Text of recommendations (long version). Liver Transpl. 2006;12:998-1011.
25. Mathurin P. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Liver Transpl 2005;11:S21-S24.
26. Lucey MR. How will patients be selected for transplantation in the future? Liver Transpl 2004; 10:S90-S92.
27. Lucey MR. Liver transplantation for alcoholic liver disease: past, present, and future. Liver Transpl 2007;13:190-192.
28. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant. Liver Transpl 2004; 10:S69-S73.
29. DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl 2006;12:813-820.
30. Pageaux GP, Bismuth M, Perney P, Costes V, Jaber S, Possoz P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003; 38:629-634.
31. Pageaux GP, Michel J, Coste V, Perney P, Possoz P, Perrigault PF, Navarro F, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999;45:421-426.
32. Lucey MR, Carr K, Beresford TP, Fisher LR, Shieck V, Brown KA, et al. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology 1997;25:1223-1227.
33. Cuadrado A, Fabrega E, Casafont F, Pons-Romero F. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2005;11:420-426.
34. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007;13:197-295.